FEATURED COMPANIES
- Abbott Laboratories
- BIOTRONIK SE & Co. KG
- Dexcom, Inc.
- Koninklijke Philips N.V.
- Medtronic Inc.
- Nihon Kohden Corporation
The global remote patient monitoring market reached a value of US$ 1.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 2.7 Billion by 2027, exhibiting a CAGR of 16.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The global remote patient monitoring (RPM) is a subset of telehealth that utilizes digital technologies to collect medical and other forms of data about the patient outside the healthcare setting. This data generally comprises weight, blood pressure, blood sugar, blood oxygen levels, heart rate and electrocardiograms, which are transmitted to healthcare providers using a telehealth computer system and software that can be installed on a computer, smartphone and tablet. RPM aids health professionals in monitoring the condition and improving the quality of care given to patients from anywhere around the world.
One of the leading factors driving the RPM market is the coronavirus disease (COVID-19) pandemic. On account of the highly infectious nature of the virus, healthcare providers across the globe are utilizing RPM services for monitoring patients with mild symptoms of COVID-19 and providing hospital-based care on a timely basis. This will aid in freeing up hospital resources for treating existing and more critical patients. Additionally, the rising prevalence of cardiovascular diseases, in confluence with the growing geriatric population, which is more susceptible to chronic conditions, represents another key factor fueling the RPM market growth. In addition to this, improving healthcare infrastructure and rapid advancements in wireless technologies, along with the increasing penetration of smartphones, are shifting healthcare services from clinic-centric to patient-centric delivery models, such as RPM. This is escalating the demand for RPM systems across the globe. Other than this, several key players are offering RPM that allows real-time video interaction between the patient and the healthcare provider. They are also introducing product innovations, which are projected to drive the market in the upcoming years. For instance, Dexcom, Inc., a US-based medical device company, launched a G6 CGM device, which is a small sensor that measures glucose levels and sends the data wirelessly to a display device through a transmitter.
2. What is the global remote patient monitoring market growth?
3. What are the global remote patient monitoring market drivers?
4. What are the key industry trends in the global remote patient monitoring market?
5. What is the impact of COVID-19 on the global remote patient monitoring market?
6. What is the global remote patient monitoring market breakup by device type?
7. What is the global remote patient monitoring market breakup by application?
8. What is the global remote patient monitoring market breakup by end use?
9. What are the major regions in the global remote patient monitoring market?
10. Who are the key companies/players in the global remote patient monitoring market?
The global remote patient monitoring (RPM) is a subset of telehealth that utilizes digital technologies to collect medical and other forms of data about the patient outside the healthcare setting. This data generally comprises weight, blood pressure, blood sugar, blood oxygen levels, heart rate and electrocardiograms, which are transmitted to healthcare providers using a telehealth computer system and software that can be installed on a computer, smartphone and tablet. RPM aids health professionals in monitoring the condition and improving the quality of care given to patients from anywhere around the world.
One of the leading factors driving the RPM market is the coronavirus disease (COVID-19) pandemic. On account of the highly infectious nature of the virus, healthcare providers across the globe are utilizing RPM services for monitoring patients with mild symptoms of COVID-19 and providing hospital-based care on a timely basis. This will aid in freeing up hospital resources for treating existing and more critical patients. Additionally, the rising prevalence of cardiovascular diseases, in confluence with the growing geriatric population, which is more susceptible to chronic conditions, represents another key factor fueling the RPM market growth. In addition to this, improving healthcare infrastructure and rapid advancements in wireless technologies, along with the increasing penetration of smartphones, are shifting healthcare services from clinic-centric to patient-centric delivery models, such as RPM. This is escalating the demand for RPM systems across the globe. Other than this, several key players are offering RPM that allows real-time video interaction between the patient and the healthcare provider. They are also introducing product innovations, which are projected to drive the market in the upcoming years. For instance, Dexcom, Inc., a US-based medical device company, launched a G6 CGM device, which is a small sensor that measures glucose levels and sends the data wirelessly to a display device through a transmitter.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global remote patient monitoring market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on device type, application and end-use.Breakup by Device Type:
- Blood Pressure Monitor
- Glucose Monitor
- Heart Rate Monitor
- Pulse Oximeters
- Respiratory Monitor
- Others
Breakup by Application:
- Cancer Treatment
- Cardiovascular Diseases Treatment and Monitoring
- Diabetes Treatment
- Sleep Disorder Treatment
- Weight Management and Fitness Monitoring
- Others
Breakup by End-Use:
- Hospitals and Clinics
- Homecare Settings
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, AMD Global Telemedicine Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Dexcom, Inc., GE Healthcare Inc. (Danaher Corporation), Honeywell International Inc., Koninklijke Philips N.V., Medtronic Inc., Nihon Kohden Corporation, OSI Systems Inc., Roche Holding AG, etc.Key Questions Answered in this Report
1. What is the market size for global remote patient monitoring market?2. What is the global remote patient monitoring market growth?
3. What are the global remote patient monitoring market drivers?
4. What are the key industry trends in the global remote patient monitoring market?
5. What is the impact of COVID-19 on the global remote patient monitoring market?
6. What is the global remote patient monitoring market breakup by device type?
7. What is the global remote patient monitoring market breakup by application?
8. What is the global remote patient monitoring market breakup by end use?
9. What are the major regions in the global remote patient monitoring market?
10. Who are the key companies/players in the global remote patient monitoring market?
Frequently Asked Questions about the Global Remote Patient Monitoring Market
What is the estimated value of the Global Remote Patient Monitoring Market?
What is the growth rate of the Global Remote Patient Monitoring Market?
What is the forecasted size of the Global Remote Patient Monitoring Market?
Who are the key companies in the Global Remote Patient Monitoring Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- BIOTRONIK SE & Co. KG
- Dexcom, Inc.
- Koninklijke Philips N.V.
- Medtronic Inc.
- Nihon Kohden Corporation
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Indicators
2 Scope and Methodology
4 Introduction
5 Global Remote Patient Monitoring Market
6 Market Breakup by Device Type
7 Market Breakup by Application
8 Market Breakup by End-Use
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Note: Product cover images may vary from those shown
- Abbott Laboratories
- AMD Global Telemedicine Inc.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Dexcom, Inc.
- GE Healthcare Inc. (Danaher Corporation)
- Honeywell International Inc.
- Koninklijke Philips N.V.
- Medtronic Inc.
- Nihon Kohden Corporation
- OSI Systems Inc.
- Roche Holding AG
Note: Product cover images may vary from those shown
LOADING...
